Full data view for gene TSC2

The curator’s expert opinion on the classification of a variant, can be found in the
SUMMARY record. Regarding the classification, please note that where there are several
records of the same variant, the classification of that variant may differ depending on the
submitter’s conclusion.

The variants shown are described using the NM_000548.3 transcript reference sequence.

Legend

Please note that a short description of a certain column can be displayed when you move your mouse cursor over the column's header and hold it still. Below, a more detailed description is shown per column.

Effect: The variant's effect on the function of the gene/protein, displayed in the format 'R/C'. R is the value reported by the source (publication, submitter) and this classification may vary between records. C is the value concluded by the curator. Note that in some database the curator uses Summary records to give details on the classification of the variant.Values used: '+' indicating the variant affects function, '+?' probably affects function, '-' does not affect function, '-?' probably does not affect function, '?' effect unknown, '.' effect was not classified.

Exon: number of exon/intron containing variant; 2 = exon 2, 12i = intron 12, 2i_7i = from intron 2 to intron 7, 8i_9 = intron 8/exon 9 boundary, _1 = 5' to exon 1, 18_ = 3' of exon 18, _1_18_ = encompassing the entire 18-exon gene

DNA change (cDNA): description of variant at DNA level, based on a coding DNA reference sequence (following HGVS recommendations); e.g. c.123C>T, c.123_145del, c.123_126dup. For deletions/duplications extending beyond the reference transcript resp. {0}/{2} is used to replace del/dup. Extent of the deletion/duplication should be specified using the genomic description (g.). "-" indicates the variant described on genomic level does not affect the coding DNA reference sequence.

RNA change: description of variant at RNA level (following HGVS recommendations).

r.123c>u
r.? = unknown
r.(?) = RNA not analysed but probably transcribed copy of DNA variant
r.spl? = RNA not analysed but variant probably affects splicing
r.(spl?) = RNA not analysed but variant may affect splicing
r.0? = change expected to abolish transcription

Protein: description of variant at protein level (following HGVS recommendations).

p.(Arg345Pro) = change predicted from DNA (RNA not analysed)
p.Arg345Pro = change derived from RNA analysis
p.? = unknown effect
p.0? = probably no protein produced

P-domain: region/domain protein affected

Predict-BioInf: predicted effect of variant using bioinformatic analysis tools (e.g. AGVGD, CADD, conservation, Grantham, MutationTaster, PolyPhen, REVEL, SIFT, splicing, etc.)

Allele: On which allele is the variant located? Does not necessarily imply inheritance! 'Paternal' (confirmed or inferred), 'Maternal' (confirmed or inferred), 'Parent #1' or #2 for compound heterozygosity without having screened the parents, 'Unknown' for heterozygosity without having screened the parents, 'Both' for homozygozity.

Classification method: The method used for the clinical classification of this variant.
All options:

ACMG
ACGS
EAHAD-CFDB
ENIGMA
IARC
InSiGHT
kConFab
other

Clinical classification: Clinical classification of variant, preferably based on standardised criteria (e.g. ACMG), directed on the clinical consequences as published/submitted, indicated using an enriched system including inheritance: e.g. pathogenic, pathogenic (dominant), pathogenic (recessive), pathogenic (!), pathogenic (maternal), pathogenic (paternal). Standard inheritance is covered by dominant/recessive, imprinting by maternal/paternal. A '!' warns for exceptional circumstances to be explained in the 'Remarks' field (low penetrance, variants pathogenic in heterozygous state only, hypomorphic/hypermorphic variants, protective variants, etc.). Non-disease consequences (e.g. drug metabolism (pharmacogenetics), risk factor, blood group, tasting bitter) are indicated using additions to the benign classification; benign (dominant), benign (recessive), benign (!), etc. The value 'association' is used for variants associated with a phenotype and 'NA' for variants from in vitro/in silico records. NOTE: classification may differ from the opinion of the curator as given in a variant SUMMARY-record or the 'Functional effect concluded'). NOTE: pathogenic/likely pathogenic should go together with "variant (probably) affects function" In ClassFunctional.
All options:

pathogenic
pathogenic (dominant)
pathogenic (recessive)
pathogenic (!)
pathogenic (maternal)
pathogenic (paternal)
likely pathogenic
likely pathogenic (dominant)
likely pathogenic (recessive)
likely pathogenic (!)
likely pathogenic (maternal)
likely pathogenic (paternal)
VUS
VUS (!)
likely benign
likely benign (dominant)
likely benign (recessive)
likely benign (!)
likely benign (maternal)
likely benign (paternal)
benign
benign (dominant)
benign (recessive)
benign (!)
benign (maternal)
benign (paternal)
conflicting
association
NA

DNA change (genomic) (hg19): HGVS description of variant at DNA level, based on the genomic (chromosomal) DNA reference sequence; e.g. g.12345678C>T, g.12345679del, g.12345678_12345890dup

DNA change (hg38): HGVS description of variant at DNA level, based on the hg38 genomic (chromosomal) eference sequence; e.g. g.12345678C>T, g.12345679del, g.12345678_12345890dup

Published as: listed only when different from "DNA change"; variant as reported originally (e.g. 521delT). Variants seen in animal models, tested in vitro, predicted from RNA analysis, etc. are described between brackets like c.(456C>G)

ISCN: description of the variant according to ISCN nomenclature

DB-ID: database ID of variant, grouping multiple observations of the same variant together, starting with the HGNC gene symbol, followed by an underscore (_) and a six digit number (e.g. DMD_012345). _000000 is used for variants where DNA was not analysed (change predicted from RNA analysis), variants seen in animal models or variants not seen in humans but functionally tested in vitro

Variant remarks: remarks regarding variant described, e.g. germline mosaicism in mother, 345 kb deletion, muscle RNA analysed, not in 200 control chromosomes tested, on founder haplotype, etc.

Reference: publication describing the variant submitted, incl. links to OMIM, PubMed or other source, e.g. "den Dunnen ASHG2003 P2346"

ClinVar ID: ID of variant in ClinVar database

dbSNP ID: the dbSNP ID

Origin: Origin of variant/record: Germline = in all cells, De novo = in all cells, but not in either parent, Germline/De novo (untested) = in all cells, parents not tested (use only when De novo is likely, e.g. isolated/sporadic cases with dominant disease), Somatic = present in a subset of cells, but not in either parent, Uniparental disomy = from parental disomy (maternal or paternal), CLASSIFICATION record = submitter only sharing variant classification (note another report may share Individual data), SUMMARY record = master summary record from curator (may link to another database), In vitro (cloned) = data resulting from in vitro functional assays, animal model = data from animal model, Artefact = false positive variant call, DUPLICATE record = variant already described on another chromosome (e.g. unbalanced translocation, duplicating transposition, 2nd fusion transcript, etc.)
All options:

Germline
De novo
Germline/De novo (untested)
Somatic
Uniparental disomy
Uniparental disomy, maternal allele
Uniparental disomy, paternal allele
CLASSIFICATION record
SUMMARY record
In vitro (cloned)
In silico
animal model
Artefact
DUPLICATE record
Unknown
Not applicable

Segregation: Indicates whether the variant segregates with the phenotype (yes), does not segregate with the phenotype (no) or segregation is unknown (?)
All options:

? = unknown
yes = segregates with phenotype
no = does not segregate with phenotype
- = not applicable

Frequency: frequency in which the variant was found; e.g 5/760 chromosomes (in 5 of 760 chromosomes tested), 1/33 patients (in 1 of 33 patients analysed in study), 0.05 controls (in 5% of control cases tested)

Re-site: restriction enzyme recognition site created (+) or destroyed (-); e.g. BglII+;BamHI-

VIP: variant VIP-status was requested for matchmaking - need collaboration(s) to crack the case - please contact the submitter/curator. NOTE: to get VIP status ask the curator.

Methylation: result of methylation test; GOM (gain of methylation), LOM (loss of methylation), 30% (30% methylated). NOTE: when several tests were done mention the method as well (e.g. MS-PCR 75%)

Template: Template(s) used to detect the sequence variant; DNA (genomic DNA), RNA (cDNA) or protein
All options:

DNA
RNA = RNA (cDNA)
protein
? = unknown

Technique: technique(s) used to identify the sequence variant.
All options:

? = unknown
ARMS = amplification refractory mutation system
arrayCGH = array for Comparative Genomic Hybridisation
arrayMET = array for methylation analysis
arraySEQ = array for resequencing
arraySNP = array for SNP typing
arrayCNV = array for Copy Number Variation (SNP and CNV probes)
ASO = allele-specific oligo hybridisation
BESS = Base Excision Sequence Scanning
CMC = Chemical Mismatch Cleavage
COBRA = Combined Bisulfite Restriction Analysis
CSCE = Conformation Sensitive Capillary Electrophoresis
CSGE = Conformation Sensitive Gel Electrophoresis
ddF = dideoxy Fingerprinting
DGGE = Denaturing-Gradient Gel-Electrophoresis
DHPLC = Denaturing High-Performance Liquid Chromatography
DOVAM = Detection Of Virtually All Mutations (SSCA variant)
DSCA = Double-Strand DNA Conformation Analysis
DSDI = Detection Small Deletions and Insertions
EMC = Enzymatic Mismatch Cleavage
expr = expression analysis
FISH = Fluorescent In-Situ Hybridisation
FISHf = fiberFISH
HD = HeteroDuplex analysis
HPLC = High-Performance Liquid Chromatography
IEF = IsoElectric Focussing
IHC = Immuno-Histo-Chemistry
Invader = Invader assay
MAPH = Multiplex Amplifiable Probe Hybridisation
MAQ = Multiplex Amplicon Quantification
MCA = Melting Curve Analysis, high-resolution (HRMA)
microscope = microscopic analysis (karyotype)
microsat = microsatellite genotyping
minigene = expression minigene construct
MIP = Molecular Inversion Probe amplification
MIPsm = single molecule Molecular Inversion Probe amplification
MLPA = Multiplex Ligation-dependent Probe Amplification
MLPA-ms = Multiplex Ligation-dependent Probe Amplification, methylation specific
MS = mass spectrometry
Northern = Northern blotting
NUC = nuclease digestion (RNAseT1, S1)
OM = optical mapping
PAGE = Poly-Acrylamide Gel-Electrophoresis
PCR = Polymerase Chain Reaction
PCRdd = PCR, digital droplet
PCRdig = PCR + restriction enzyme digestion
PCRh = PCR, haloplex
PCRlr = PCR, long-range
PCRm = PCR, multiplex
PCRms = PCR, methylation sensitive
PCRq = PCR, quantitative (qPCR)
PCRrp = PCR, repeat-primed (RP-PCR)
PCRsqd = PCR, semi-quantitative duplex
PE = primer extension (APEX, SNaPshot)
PEms = primer extension, methylation-sensitive single-nucleotide
PFGE = Pulsed-Field Gel-Electrophoresis (+Southern)
PTT = Protein Truncation Test
RFLP = Restriction Fragment Length Polymorphisms
RT-PCR = Reverse Transcription and PCR
RT-PCRq = Reverse Transcription and PCR, quantitative
SBE = Single Base Extension
SEQ = SEQuencing (Sanger)
SEQb = bisulfite SEQuencing
SEQp = pyroSequencing
SEQms = sequencing, methylation specific
SEQ-ON = next-generation sequencing - Oxford Nanopore
SEQ-NG = next-generation sequencing
SEQ-NG-RNA = next-generation sequencing RNA
SEQ-NG-H = next-generation sequencing - Helicos
SEQ-NG-I = next-generation sequencing - Illumina/Solexa
SEQ-NG-IT = next-generation sequencing - Ion Torrent
SEQ-NG-R = next-generation sequencing - Roche/454
SEQ-NG-S = next-generation sequencing - SOLiD
SEQ-PB = next-generation sequencing - Pacific Biosciences
SNPlex = SNPlex
Southern = Southern blotting
SSCA = Single-Strand DNA Conformation polymorphism Analysis (SSCP)
SSCAf = fluorescent SSCA (SSCP)
STR = Short Tandem Repeat
TaqMan = TaqMan assay
Western = Western blotting
- = not applicable

Tissue: tissue type used for analysis

Remarks: remarks regarding the screening like WGS (whole genome sequencing), WES (whole exome sequencing, gene panel (incl. a list of genes analysed), etc.

ID_report: ID of the individual that can be publically shared, e.g. as listed in a publication

Reference: reference to publication describing the individual/family, possibly giving more phenotypic details than listed in this database entry, incl. link to PubMed or other source, e.g. "den Dunnen ASHG2003 P2346"

Remarks: remarks about the individual

Gender: gender individual
All options:

? = unknown
- = not applicable
F = female
M = male
rF = raised as female
rM = raised as male

Consanguinity: indicates whether the parents are related (consanguineous), not related (non-consanguineous) or whether consanguinity is not known (unknown)
All options:

no = non-consanguineous parents
yes = consanguineous parents
likely = consanguinity likely
? = unknown
- = not applicable

Country: where (country) does the individual live/recently came from. Give additional details (population, specific sub-group) and when parents come from different countries in "Population". Belgium = individual lives in/recently came from Belgium, (France) = reported by laboratory in France, individual's country of origin not sure
All options:

? (unknown)
- (not applicable)
Afghanistan
(Afghanistan)
Albania
(Albania)
Algeria
(Algeria)
American Samoa
(American Samoa)
Andorra
(Andorra)
Angola
(Angola)
Anguilla
(Anguilla)
Antarctica
(Antarctica)
Antigua and Barbuda
(Antigua and Barbuda)
Argentina
(Argentina)
Armenia
(Armenia)
Aruba
(Aruba)
Australia
(Australia)
Austria
(Austria)
Azerbaijan
(Azerbaijan)
Bahamas
(Bahamas)
Bahrain
(Bahrain)
Bangladesh
(Bangladesh)
Barbados
(Barbados)
Belarus
(Belarus)
Belgium
(Belgium)
Belize
(Belize)
Benin
(Benin)
Bermuda
(Bermuda)
Bhutan
(Bhutan)
Bolivia
(Bolivia)
Bosnia and Herzegovina
(Bosnia and Herzegovina)
Botswana
(Botswana)
Bouvet Island
(Bouvet Island)
Brazil
(Brazil)
British Indian Ocean Territory
(British Indian Ocean Territory)
Brunei Darussalam
(Brunei Darussalam)
Bulgaria
(Bulgaria)
Burkina Faso
(Burkina Faso)
Burundi
(Burundi)
Cambodia
(Cambodia)
Cameroon
(Cameroon)
Canada
(Canada)
Cape Verde
(Cape Verde)
Cayman Islands
(Cayman Islands)
Central African Republic
(Central African Republic)
Central Europe
Chad
(Chad)
Chile
(Chile)
China
(China)
Christmas Island
(Christmas Island)
Cocos (Keeling Islands)
(Cocos (Keeling Islands))
Colombia
(Colombia)
Comoros
(Comoros)
Congo
(Congo)
Cook Islands
(Cook Islands)
Costa Rica
(Costa Rica)
Cote D'Ivoire (Ivory Coast)
(Cote D'Ivoire (Ivory Coast))
Croatia (Hrvatska)
(Croatia (Hrvatska))
Cuba
(Cuba)
Cyprus
(Cyprus)
Czech Republic
(Czech Republic)
Denmark
(Denmark)
Djibouti
(Djibouti)
Dominica
(Dominica)
Dominican Republic
(Dominican Republic)
East Timor
(East Timor)
Ecuador
(Ecuador)
Egypt
(Egypt)
El Salvador
(El Salvador)
England
(England)
Equatorial Guinea
(Equatorial Guinea)
Eritrea
(Eritrea)
Estonia
(Estonia)
Ethiopia
(Ethiopia)
Falkland Islands (Malvinas)
(Falkland Islands (Malvinas))
Faroe Islands
(Faroe Islands)
Fiji
(Fiji)
Finland
(Finland)
France
(France)
Gabon
(Gabon)
Gambia
(Gambia)
Georgia
(Georgia)
Germany
(Germany)
Ghana
(Ghana)
Gibraltar
(Gibraltar)
Greece
(Greece)
Greenland
(Greenland)
Grenada
(Grenada)
Guadeloupe
(Guadeloupe)
Guam
(Guam)
Guatemala
(Guatemala)
Guiana, French
(Guiana, French)
Guinea
(Guinea)
Guinea-Bissau
(Guinea-Bissau)
Guyana
(Guyana)
Haiti
(Haiti)
Heard and McDonald Islands
(Heard and McDonald Islands)
Honduras
(Honduras)
Hong Kong
(Hong Kong)
Hungary
(Hungary)
Iceland
(Iceland)
India
(India)
Indonesia
(Indonesia)
Iran
(Iran)
Iraq
(Iraq)
Ireland
(Ireland)
Israel
(Israel)
Italy
(Italy)
Jamaica
(Jamaica)
Japan
(Japan)
Jordan
(Jordan)
Kazakhstan
(Kazakhstan)
Kenya
(Kenya)
Kiribati
(Kiribati)
Korea
(Korea)
Korea, North (People's Republic)
(Korea, North (People's Republic))
Korea, South (Republic)
(Korea, South (Republic))
Kosovo
(Kosovo)
Kuwait
(Kuwait)
Kyrgyzstan (Kyrgyz Republic)
(Kyrgyzstan (Kyrgyz Republic))
Laos
(Laos)
Latvia
(Latvia)
Lebanon
(Lebanon)
Lesotho
(Lesotho)
Liberia
(Liberia)
Libya
(Libya)
Liechtenstein
(Liechtenstein)
Lithuania
(Lithuania)
Luxembourg
(Luxembourg)
Macau
(Macau)
Macedonia
(Macedonia)
Madagascar
(Madagascar)
Malawi
(Malawi)
Malaysia
(Malaysia)
Maldives
(Maldives)
Mali
(Mali)
Mallorca
(Mallorca)
Malta
(Malta)
Marshall Islands
(Marshall Islands)
Martinique
(Martinique)
Mauritania
(Mauritania)
Mauritius
(Mauritius)
Mayotte
(Mayotte)
Mexico
(Mexico)
Micronesia
(Micronesia)
Moldova
(Moldova)
Monaco
(Monaco)
Mongolia
(Mongolia)
Montserrat
(Montserrat)
Morocco
(Morocco)
Mozambique
(Mozambique)
Myanmar
(Myanmar)
Namibia
(Namibia)
Nauru
(Nauru)
Nepal
(Nepal)
Netherlands
(Netherlands)
Netherlands Antilles
(Netherlands Antilles)
Neutral Zone (Saudia Arabia/Iraq)
(Neutral Zone (Saudia Arabia/Iraq))
New Caledonia
(New Caledonia)
New Zealand
(New Zealand)
Nicaragua
(Nicaragua)
Niger
(Niger)
Nigeria
(Nigeria)
Niue
(Niue)
Norfolk Island
(Norfolk Island)
Northern Ireland
(Northern Ireland)
Northern Mariana Islands
(Northern Mariana Islands)
Norway
(Norway)
Oman
(Oman)
Pakistan
(Pakistan)
Palau
(Palau)
Palestine
(Palestine)
Panama
(Panama)
Papua New Guinea
(Papua New Guinea)
Paraguay
(Paraguay)
Peru
(Peru)
Philippines
(Philippines)
Pitcairn
(Pitcairn)
Poland
(Poland)
Polynesia, French
(Polynesia, French)
Portugal
(Portugal)
Puerto Rico
(Puerto Rico)
Qatar
(Qatar)
Reunion
(Reunion)
Romania
(Romania)
Russia
(Russia)
Russian Federation
(Russian Federation)
Rwanda
(Rwanda)
S. Georgia and S. Sandwich Isls.
(S. Georgia and S. Sandwich Isls.)
Saint Kitts and Nevis
(Saint Kitts and Nevis)
Saint Lucia
(Saint Lucia)
Saint Vincent and The Grenadines
(Saint Vincent and The Grenadines)
Samoa
(Samoa)
San Marino
(San Marino)
Sao Tome and Principe
(Sao Tome and Principe)
Saudi Arabia
(Saudi Arabia)
Scotland
(Scotland)
Senegal
(Senegal)
Serbia
(Serbia)
Seychelles
(Seychelles)
Sierra Leone
(Sierra Leone)
Singapore
(Singapore)
Slovakia (Slovak Republic)
(Slovakia (Slovak Republic))
Slovenia
(Slovenia)
Solomon Islands
(Solomon Islands)
Somalia
(Somalia)
South Africa
(South Africa)
Southern Territories, French
(Southern Territories, French)
Soviet Union (former)
(Soviet Union (former))
Spain
(Spain)
Sri Lanka
(Sri Lanka)
St. Helena, Ascension and Tristan da
Cunha
(St. Helena, Ascension and Tristan da
Cunha)
St. Pierre and Miquelon
(St. Pierre and Miquelon)
Sudan
(Sudan)
Sudan, South
(Sudan, South)
Suriname
(Suriname)
Svalbard and Jan Mayen Islands
(Svalbard and Jan Mayen Islands)
Swaziland
(Swaziland)
Sweden
(Sweden)
Switzerland
(Switzerland)
Syria
(Syria)
Taiwan
(Taiwan)
Tajikistan
(Tajikistan)
Tanzania
(Tanzania)
Thailand
(Thailand)
Togo
(Togo)
Tokelau
(Tokelau)
Tonga
(Tonga)
Trinidad and Tobago
(Trinidad and Tobago)
Tunisia
(Tunisia)
Turkey
(Turkey)
Turkmenistan
(Turkmenistan)
Turks and Caicos Islands
(Turks and Caicos Islands)
Tuvalu
(Tuvalu)
Uganda
(Uganda)
Ukraine
(Ukraine)
United Arab Emirates
(United Arab Emirates)
United Kingdom (Great Britain)
(United Kingdom (Great Britain))
United States
(United States)
Uruguay
(Uruguay)
US Minor Outlying Islands
(US Minor Outlying Islands)
Uzbekistan
(Uzbekistan)
Vanuatu
(Vanuatu)
Vatican City State (Holy See)
(Vatican City State (Holy See))
Venezuela
(Venezuela)
Viet Nam
(Viet Nam)
Virgin Islands (British)
(Virgin Islands (British))
Virgin Islands (US)
(Virgin Islands (US))
Wales
(Wales)
Wallis and Futuna Islands
(Wallis and Futuna Islands)
Western Sahara
(Western Sahara)
Yemen
(Yemen)
Yugoslavia
(Yugoslavia)
Zaire
(Zaire)
Zambia
(Zambia)
Zimbabwe
(Zimbabwe)

Population: population the individual (or ancestors) belongs to; e.g. white, gypsy, Jewish-Ashkenazi, Africa-N, Sardinia, etc.

Age at death: age at which the individual deceased (when applicable):

35y = 35 years
>43y = still alive at 43y
04y08m = 4 years and 8 months
00y00m01d12h = 1 day and 12 hours
18y? = around 18 years
30y-40y = between 30 and 40 years
>54y = older than 54
? = unknown

VIP: individual/phenotype VIP-status was requested for matchmaking - need collaboration(s) to crack the case - please contact the submitter/curator. NOTE: to get VIP status ask the curator.

Data_av: are additional data available upon request: e.g. pedigree (yes/no/?)

Treatment: treatment of patient

How to query this table

All list views have search fields which can be used to search data. You can search for a complete word or you can search for a part of a search term. If you enclose two or more words in double quotes, LOVD will search for the combination of those words only exactly in the order you specify. Note that search terms are case-insensitive and that wildcards such as * are treated as normal text! For all options, like "and", "or", and "not" searches, or searching for prefixes or suffixes, see the table below.

Operator	Column type	Example	Matches
	Text	Arg	all entries containing 'Arg'
space	Text	Arg Ser	all entries containing 'Arg' and 'Ser'
\|	Text	Arg\|Ser	all entries containing 'Arg' or 'Ser'
!	Text	!fs	all entries not containing 'fs'
^	Text	^p.(Arg	all entries beginning with 'p.(Arg'
$	Text	Ser)$	all entries ending with 'Ser)'
=""	Text	=""	all entries with this field empty
=""	Text	="p.0"	all entries exactly matching 'p.0'
!=""	Text	!=""	all entries with this field not empty
!=""	Text	!="p.0"	all entries not exactly matching 'p.0?'
combination	Text	*\|Ter !fs	all entries containing '*' or 'Ter' but not containing 'fs'
	Date	2020	all entries matching the year 2020
\|	Date	2020-03\|2020-04	all entries matching March or April, 2020
!	Date	!2020-03	all entries not matching March, 2020
<	Date	<2020	all entries before the year 2020
<=	Date	<=2020-06	all entries in or before June, 2020
>	Date	>2020-06	all entries after June, 2020
>=	Date	>=2020-06-15	all entries on or after June 15th, 2020
combination	Date	2019\|2020 <2020-03	all entries in 2019 or 2020, and before March, 2020
	Numeric	23	all entries exactly matching 23
\|	Numeric	23\|24	all entries exactly matching 23 or 24
!	Numeric	!23	all entries not exactly matching 23
<	Numeric	<23	all entries lower than 23
<=	Numeric	<=23	all entries lower than, or equal to, 23
>	Numeric	>23	all entries higher than 23
>=	Numeric	>=23	all entries higher than, or equal to, 23
combination	Numeric	>=20 <30 !23	all entries with values from 20 to 29, but not equal to 23

Some more advanced examples:

Example	Matches
Asian	all entries containing 'Asian', 'asian', including 'Caucasian', 'caucasian', etc.
Asian !Caucasian	all entries containing 'Asian' but not containing 'Caucasian'
Asian\|African !Caucasian	all entries containing 'Asian' or 'African', but not containing 'Caucasian'
"South Asian"	all entries containing 'South Asian', but not containing 'South East Asian'

To sort on a certain column, click on the column header or on the arrows. If that column is already selected to sort on, the sort order will be swapped. The column currently sorted on has a darker blue background color than the other columns. The up and down arrows next to the column name indicate the current sorting direction. When sorting on any field other than the default, LOVD will sort secondarily on the default sort column.

50 entries on 1 page. Showing entries 1 - 50.

Legend

How to query

Effect	Exon	DNA change (cDNA)	RNA change	Protein	P-domain	Predict-BioInf	Allele	Classification method	Clinical classification	DNA change (genomic) (hg19)	DNA change (hg38)	Published as	ISCN	DB-ID	Variant remarks	Reference	ClinVar ID	dbSNP ID	Origin	Segregation	Frequency	Re-site	VIP	Methylation	Template	Technique	Tissue	Remarks	Disease	ID_report	Reference	Remarks	Gender	Consanguinity	Country	Population	Age at death	VIP	Data_av	Treatment	Panel size	Owner
+/.	-	c.1372C>T	r.(?)	p.(Arg458Ter)	-	-	Unknown	-	pathogenic	g.2112983C>T	g.2062982C>T	TSC2(NM_000548.3):c.1372C>T (p.R458*)	-	TSC2_000070	VKGL data sharing initiative Nederland	-	-	-	CLASSIFICATION record	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
+/+	14	c.1372C>T	r.(?)	p.(Arg458*)	Hamartin binding domain	-	Unknown	-	pathogenic (dominant)	g.2112983C>T	g.2062982C>T	-	-	TSC2_000070	-	-	-	-	SUMMARY record	-	-	DdeI+, AvaI-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
+/.	14	c.1372C>T	r.(?)	p.(Arg458*)	Hamartin binding domain	-	Unknown	-	pathogenic	g.2112983C>T	g.2062982C>T	1390C>T	-	TSC2_000070	-	unpublished	-	-	Germline	-	-	DdeI+, AvaI-	-	-	DNA	DHPLC	Blood	-	TSC	-	unpublished	3rd patient	?	-	-	-	-	-	-	-	1	Rosemary Ekong
+/.	14	c.1372C>T	r.(?)	p.(Arg458*)	Hamartin binding domain	-	Unknown	-	pathogenic	g.2112983C>T	g.2062982C>T	decsribed as 1390C>T	-	TSC2_000070	-	unpublished	-	-	Germline	-	-	DdeI+, AvaI-	-	-	DNA	DHPLC	Blood	-	TSC	-	unpublished	-	?	-	-	-	-	-	-	-	1	Rosemary Ekong
+/.	14	c.1372C>T	r.(?)	p.(Arg458*)	Hamartin binding domain	-	Unknown	-	pathogenic	g.2112983C>T	g.2062982C>T	1390C>T	-	TSC2_000070	-	unpublished	-	-	Germline	-	-	DdeI+, AvaI-	-	-	DNA	DHPLC	Blood	-	TSC	-	unpublished	different patient	?	-	-	-	-	-	-	-	1	Rosemary Ekong
+/.	14	c.1372C>T	r.(?)	p.(Arg458*)	Hamartin binding domain	-	Unknown	-	pathogenic	g.2112983C>T	g.2062982C>T	-	-	TSC2_000070	-	PubMed: Au, 2007	-	-	Germline	-	-	DdeI+, AvaI-	-	-	DNA	SSCA	Blood	-	TSC	HOU14-06	PubMed: Au, 2007	-	?	-	-	-	-	-	-	-	2	Rosemary Ekong
+/.	14	c.1372C>T	r.(?)	p.(Arg458*)	Hamartin binding domain	-	Unknown	-	pathogenic	g.2112983C>T	g.2062982C>T	-	-	TSC2_000070	-	PubMed: Au, 2007	-	-	Germline	-	-	DdeI+, AvaI-	-	-	DNA	SEQ	Blood	-	TSC	TS00-120	PubMed: Au, 2007	-	?	-	-	-	-	-	-	-	1	Rosemary Ekong
+/.	14	c.1372C>T	r.(?)	p.(Arg458*)	Hamartin binding domain	-	Unknown	-	pathogenic	g.2112983C>T	g.2062982C>T	-	-	TSC2_000070	-	PubMed: Rose, 1999, PubMed: Au, 2007	-	-	Germline	-	-	DdeI+, AvaI-	-	-	DNA	SSCA, ASO	Blood	-	TSC	HOU34-04	PubMed: Rose, 1999, PubMed: Au, 2007	variant present in 2 affected siblings, but not in unaffected parents; germline mosaicism in either parent; somatic mosaicism absent in lymphocytic DNA	?	-	-	-	-	-	-	-	2	Rosemary Ekong
+/.	14	c.1372C>T	r.(?)	p.(Arg458*)	Hamartin binding domain	-	Unknown	-	pathogenic	g.2112983C>T	g.2062982C>T	-	-	TSC2_000070	-	PubMed: Dabora, 2001	-	-	Germline	-	-	DdeI+, AvaI-	-	-	DNA	DHPLC	Blood	-	TSC	ONK351	PubMed: Dabora, 2001	patient with clinical diagnosis of TS; no FH of TS	?	-	-	-	-	-	-	-	1	Rosemary Ekong
+/.	14	c.1372C>T	r.(?)	p.(Arg458*)	Hamartin binding domain	-	Unknown	-	pathogenic	g.2112983C>T	g.2062982C>T	-	-	TSC2_000070	-	PubMed: Dabora, 2001	-	-	Germline	-	-	DdeI+, AvaI-	-	-	DNA	DHPLC	Blood	-	TSC	ONK881	PubMed: Dabora, 2001	different case	?	-	-	-	-	-	-	-	1	Rosemary Ekong
+/.	14	c.1372C>T	r.(?)	p.(Arg458*)	Hamartin binding domain	-	Unknown	-	pathogenic	g.2112983C>T	g.2062982C>T	-	-	TSC2_000070	-	PubMed: Dabora, 2001, PubMed: Roberts, 2004	-	-	De novo	-	-	DdeI+, AvaI-	-	-	DNA	DHPLC	Blood	-	TSC	BHM5701	PubMed: Dabora, 2001, PubMed: Roberts, 2004	both parents considered unaffected, both tested and variant absent; mosaicism above the level of 1% not detected in patient or parents	?	-	-	-	-	-	-	-	1	Rosemary Ekong
+/.	14	c.1372C>T	r.(?)	p.(Arg458*)	Hamartin binding domain	-	Unknown	-	pathogenic	g.2112983C>T	g.2062982C>T	-	-	TSC2_000070	-	PubMed: Dabora, 2001, PubMed: Roberts, 2004	-	-	Germline	-	-	DdeI+, AvaI-	-	-	DNA	DHPLC	Blood	-	TSC	BHM4701	PubMed: Dabora, 2001, PubMed: Roberts, 2004	the one parent available was considered unaffected and tested - variant absent; mosaicism above the level of 1% not detected in patient or parent tested	?	-	-	-	-	-	-	-	1	Rosemary Ekong
+/.	14	c.1372C>T	r.(?)	p.(Arg458*)	Hamartin binding domain	-	Unknown	-	pathogenic	g.2112983C>T	g.2062982C>T	-	-	TSC2_000070	-	originally Kwiatkowski database	-	-	Germline	-	-	DdeI+, AvaI-	-	-	DNA	?	Blood	-	TSC	-	originally Kwiatkowski database	3/8 reports represented by this entry; 5/8 reports accounted for in Dabora, 2001 and Roberts, 2004; total of 8 reports in Harvard db	?	-	-	-	-	-	-	-	1	Rosemary Ekong
+/.	14	c.1372C>T	r.(?)	p.(Arg458*)	Hamartin binding domain	-	Unknown	-	pathogenic	g.2112983C>T	g.2062982C>T	-	-	TSC2_000070	-	unpublished	-	-	Germline	-	-	DdeI+, AvaI-	-	-	DNA	DHPLC	Blood	-	TSC	-	unpublished	-	?	-	-	-	-	-	-	-	1	Rosemary Ekong
+/.	14	c.1372C>T	r.(?)	p.(Arg458*)	Hamartin binding domain	-	Unknown	-	pathogenic	g.2112983C>T	g.2062982C>T	-	-	TSC2_000070	both TSC1 and TSC2 genes tested	unpublished	-	-	Germline	-	-	DdeI+, AvaI-	-	-	DNA	SEQ	Blood	-	TSC	-	unpublished	-	M	-	-	-	-	-	-	-	1	Rosemary Ekong
+/.	14	c.1372C>T	r.(?)	p.(Arg458*)	Hamartin binding domain	-	Unknown	-	pathogenic	g.2112983C>T	g.2062982C>T	-	-	TSC2_000070	-	unpublished	-	-	Germline	-	-	DdeI+, AvaI-	-	-	DNA	DHPLC	Blood	-	TSC	-	unpublished	-	F	-	-	-	-	-	-	-	1	Rosemary Ekong
+/.	14	c.1372C>T	r.(?)	p.(Arg458*)	Hamartin binding domain	-	Unknown	-	pathogenic	g.2112983C>T	g.2062982C>T	-	-	TSC2_000070	-	unpublished	-	-	Germline	-	-	DdeI+, AvaI-	-	-	DNA	DHPLC	Blood	-	TSC	-	unpublished	-	M	-	-	-	-	-	-	-	1	Rosemary Ekong
+/.	14	c.1372C>T	r.(?)	p.(Arg458*)	Hamartin binding domain	-	Unknown	-	pathogenic	g.2112983C>T	g.2062982C>T	-	-	TSC2_000070	-	PubMed: Tsai, 2011	-	-	Germline	-	-	DdeI+, AvaI-	-	-	DNA	SEQ	Blood	-	TSC	42	PubMed: Tsai, 2011	variant seen in patient and 2 other affected family members	?	-	Taiwan	-	-	-	-	-	3	Rosemary Ekong
+/.	14	c.1372C>T	r.(?)	p.(Arg458*)	Hamartin binding domain	-	Unknown	-	pathogenic	g.2112983C>T	g.2062982C>T	-	-	TSC2_000070	small and large changes screened; MLPA kits P124 (TSC1) & P046B2 (TSC2) used	unpublished	-	-	Germline	-	-	DdeI+, AvaI-	-	-	DNA	SEQ, MLPA	Blood	-	TSC	-	unpublished	TS affected	M	-	-	-	-	-	-	-	1	Rosemary Ekong
+/.	14	c.1372C>T	r.(?)	p.(Arg458*)	Hamartin binding domain	-	Unknown	-	pathogenic	g.2112983C>T	g.2062982C>T	c.1372C>T	-	TSC2_000070	-	PubMed: Sancak, 2005	-	-	Germline	-	-	DdeI+, AvaI-	-	-	DNA	SEQ	Blood	-	TSC	-	PubMed: Sancak, 2005	diagnosed with definite TSC	?	-	-	-	-	-	-	-	2	Rosemary Ekong
+/.	14	c.1372C>T	r.(?)	p.(Arg458*)	Hamartin binding domain	-	Unknown	-	pathogenic	g.2112983C>T	g.2062982C>T	c.1372C>T	-	TSC2_000070	-	PubMed: Sancak, 2005	-	-	Germline	-	-	DdeI+, AvaI-	-	-	DNA	SEQ	Blood	-	TSC	-	PubMed: Sancak, 2005	2 different cases; both diagnosed with definite TSC	?	-	-	-	-	-	-	-	2	Rosemary Ekong
+/.	14	c.1372C>T	r.(?)	p.(Arg458*)	Hamartin binding domain	-	Unknown	-	pathogenic	g.2112983C>T	g.2062982C>T	c.1372C>T	-	TSC2_000070	-	unpublished	-	-	Germline	-	-	DdeI+, AvaI-	-	-	DNA	SEQ	Blood	-	TSC	-	unpublished	2 different cases	?	-	-	-	-	-	-	-	2	Rosemary Ekong
+/.	14	c.1372C>T	r.(?)	p.(Arg458*)	Hamartin binding domain	-	Unknown	-	pathogenic	g.2112983C>T	g.2062982C>T	-	-	TSC2_000070	found with commmon TSC1 variants c.965T>C and c.1335A>G; and TSC2 missense c.704G>A	unpublished	-	-	Germline	-	-	DdeI+, AvaI-	-	-	DNA	DHPLC	Blood	-	TSC	-	unpublished	-	M	-	-	-	-	-	-	-	1	Rosemary Ekong
+/.	14	c.1372C>T	r.(?)	p.(Arg458*)	Hamartin binding domain	-	Unknown	-	pathogenic	g.2112983C>T	g.2062982C>T	-	-	TSC2_000070	variant detected at low level; complete screen; MLPA kits P124 (TSC1), P046 (TSC2)	unpublished	-	-	Germline	-	-	DdeI+, AvaI-	-	-	DNA	SEQ, MLPA	Blood	-	TSC	-	unpublished	somatic mosaicism in patient; parents not tested	?	-	-	-	-	-	-	-	1	Rosemary Ekong
+/.	14	c.1372C>T	r.(?)	p.(Arg458*)	Hamartin binding domain	-	Unknown	-	pathogenic	g.2112983C>T	g.2062982C>T	-	-	TSC2_000070	-	unpublished	-	-	Germline	-	-	DdeI+, AvaI-	-	-	DNA	SEQ	Blood	-	TSC	-	unpublished	index diagnosed with possible TSC; one parent tested; this parent does not show clinical signs of TS and does not have the variant; other parent not tested	M	-	-	-	-	-	-	-	1	Rosemary Ekong
+/.	14	c.1372C>T	r.(?)	p.(Arg458*)	Hamartin binding domain	-	Unknown	-	pathogenic	g.2112983C>T	g.2062982C>T	-	-	TSC2_000070	-	unpublished	-	-	Germline	-	-	DdeI+, AvaI-	-	-	DNA	SEQ	Blood	-	TSC	-	unpublished	sibling tested and variant not found; one parent reported to have epilepsy but not tested	M	-	-	-	-	-	-	-	1	Rosemary Ekong
+/.	14	c.1372C>T	r.(?)	p.(Arg458*)	Hamartin binding domain	-	Unknown	-	pathogenic	g.2112983C>T	g.2062982C>T	-	-	TSC2_000070	reported as disease-associated mutation; entire TSC1 and TSC2 genes sequenced; deletion test not done	unpublished	-	-	Germline	-	-	DdeI+, AvaI-	-	-	DNA	SEQ	Blood	-	TSC	-	unpublished	TS affected; affected relative tested also has the variant	F	-	-	-	-	-	-	-	2	Rosemary Ekong
+/.	14	c.1372C>T	r.(?)	p.(Arg458*)	Hamartin binding domain	-	Unknown	-	pathogenic	g.2112983C>T	g.2062982C>T	-	-	TSC2_000070	-	PubMed: Roberts, 2004	-	-	De novo	-	-	DdeI+, AvaI-	-	-	DNA	DHPLC, SEQ	Blood	-	TSC	BHM1001	PubMed: Roberts, 2004	both parents considered unaffected, both tested and variant absent; mosaicism above the level of 1% not detected in patient or parents	?	-	-	-	-	-	-	-	1	Rosemary Ekong
+/.	14	c.1372C>T	r.(?)	p.(Arg458*)	Hamartin binding domain	-	Unknown	-	pathogenic	g.2112983C>T	g.2062982C>T	-	-	TSC2_000070	-	PubMed: Kwiatkowski, 2015	-	-	Germline	-	-	DdeI+, AvaI-	-	-	DNA	SEQ	Blood	-	TSC	-	PubMed: Kwiatkowski, 2015	patients have subependymal giant cell astrocytomas associated with tuberous sclerosis complex	?	-	-	-	-	-	-	-	2	Rosemary Ekong
+/.	14	c.1372C>T	r.(?)	p.(Arg458*)	Hamartin binding domain	-	Unknown	-	pathogenic	g.2112983C>T	g.2062982C>T	-	-	TSC2_000070	-	PubMed: Kwiatkowski, 2015	-	-	Germline	-	-	DdeI+, AvaI-	-	-	DNA	SEQ	Blood	-	TSC	-	PubMed: Kwiatkowski, 2015	patient has TSC with AML	?	-	-	-	-	-	-	-	1	Rosemary Ekong
+/.	14	c.1372C>T	r.(?)	p.(Arg458*)	Hamartin binding domain	-	Unknown	-	pathogenic	g.2112983C>T	g.2062982C>T	-	-	TSC2_000070	-	unpublished	-	-	De novo	-	-	DdeI+, AvaI-	-	-	DNA	SEQ	Blood	-	TSC	-	unpublished	1 affected in 1 generation; parents tested and variant not found	?	-	-	-	-	-	-	-	1	Rosemary Ekong
+/.	14	c.1372C>T	r.(?)	p.(Arg458*)	Hamartin binding domain	-	Unknown	-	pathogenic	g.2112983C>T	g.2062982C>T	-	-	TSC2_000070	-	unpublished	-	-	De novo	-	-	DdeI+, AvaI-	-	-	DNA	SEQ	Blood	-	TSC	-	unpublished	1 affected in 1 generation; parents tested and variant not found	?	-	-	-	-	-	-	-	1	Rosemary Ekong
+/.	14	c.1372C>T	r.(?)	p.(Arg458*)	Hamartin binding domain	-	Unknown	-	pathogenic	g.2112983C>T	g.2062982C>T	-	-	TSC2_000070	-	unpublished	-	-	De novo	-	-	DdeI+, AvaI-	-	-	DNA	SEQ	Blood	-	TSC	-	unpublished	1 affected in 1 generation; parents tested and variant not found	?	-	-	-	-	-	-	-	1	Rosemary Ekong
+/.	14	c.1372C>T	r.(?)	p.(Arg458*)	Hamartin binding domain	-	Unknown	-	pathogenic	g.2112983C>T	g.2062982C>T	-	-	TSC2_000070	-	unpublished	-	-	De novo	-	-	DdeI+, AvaI-	-	-	DNA	SEQ	Blood	-	TSC	-	unpublished	ASK NICOLA IF BOTH PARENTS TESTED AS CONTRADICTORY REMARKS - RECHECK ALL TEXT IN EVERY WINDOW; 2 TS affected children but only one of the affected children and one or both??? parents and a sibling??? tested for TSC2 c.1372C>T; both parents reported as healthy and TSC2 c.1372C>T absent in both???; reported that possible germline mosaicism in one of the parents???; one of the parents and a sibling have TSC2 c.2476C>A	?	-	-	-	-	-	-	-	1	Rosemary Ekong
+/.	14	c.1372C>T	r.(?)	p.(Arg458*)	Hamartin binding domain	-	Unknown	-	pathogenic	g.2112983C>T	g.2062982C>T	-	-	TSC2_000070	-	unpublished	-	-	De novo	-	-	DdeI+, AvaI-	-	-	DNA	DHPLC, SEQ	Blood	-	TSC	-	unpublished	both parents tested negative	F	-	-	-	-	-	-	-	1	Rosemary Ekong
+/.	14	c.1372C>T	r.(?)	p.(Arg458*)	Hamartin binding domain	-	Unknown	-	pathogenic	g.2112983C>T	g.2062982C>T	-	-	TSC2_000070	-	unpublished	-	-	De novo	-	-	DdeI+, AvaI-	-	-	DNA	DHPLC, SEQ	Blood	-	TSC	-	unpublished	both parents tested negative for variant	F	-	-	-	-	-	-	-	1	Rosemary Ekong
+/.	14	c.1372C>T	r.(?)	p.(Arg458*)	Hamartin binding domain	-	Unknown	-	pathogenic	g.2112983C>T	g.2062982C>T	-	-	TSC2_000070	found with TSC2 intronic variant c.3883+8C>G	unpublished	-	-	Germline	-	-	DdeI+, AvaI-	-	-	DNA	DHPLC, SEQ	Blood	-	TSC	-	unpublished	patient has TSC2 nonsense c.1372C>T and TSC2 intronic variant c.3883+8C>G; the one parent tested is negative for TSC2 nonsense c.1372C>T; inheritance of TSC2 c.3883+8C>G not indicated	M	-	-	-	-	-	-	-	1	Rosemary Ekong
+/.	14	c.1372C>T	r.(?)	p.(Arg458*)	Hamartin binding domain	-	Unknown	-	pathogenic	g.2112983C>T	g.2062982C>T	p.Arg458Ter	-	TSC2_000070	NGS at 30% coverage and 280.4x sequencing depth	PubMed: Cai, 2017	-	-	Germline	-	-	DdeI+, AvaI-	-	-	DNA	SEQ-NG-I	Blood	-	TSC	8-F	PubMed: Cai, 2017	family with 2 affected individuals and both with the variant; both diagnosed with definite TSC and accompanied by renal lesions (either renal AML or renal cysts)	?	-	China	-	-	-	-	-	3	Rosemary Ekong
+/.	14	c.1372C>T	r.(?)	p.(Arg458*)	Hamartin binding domain	-	Unknown	-	pathogenic	g.2112983C>T	g.2062982C>T	-	-	TSC2_000070	-	unpublished	-	-	De novo	-	-	DdeI+, AvaI-	-	-	DNA	SEQ	Blood	-	TSC	-	unpublished	both parents tested and variant absent	?	-	-	-	-	-	-	-	1	Rosemary Ekong
+/.	14	c.1372C>T	r.(?)	p.(Arg458*)	Hamartin binding domain	-	Unknown	-	pathogenic	g.2112983C>T	g.2062982C>T	-	-	TSC2_000070	-	unpublished	-	-	Germline	-	-	DdeI+, AvaI-	-	-	DNA	SEQ	Blood	-	TSC	-	unpublished	-	?	-	-	-	-	-	-	-	1	Rosemary Ekong
+/.	14	c.1372C>T	r.(?)	p.(Arg458*)	Hamartin binding domain	-	Unknown	-	pathogenic	g.2112983C>T	g.2062982C>T	-	-	TSC2_000070	-	unpublished	-	-	Germline	-	-	DdeI+, AvaI-	-	-	DNA	SEQ-NG-I	Blood	-	TSC	-	unpublished	patients with clinical symptoms	M	-	Spain	-	-	-	-	-	2	Rosemary Ekong
+/.	14	c.1372C>T	r.(?)	p.(Arg458*)	-	-	Paternal (confirmed)	ACMG	pathogenic (dominant)	g.2112983C>T	g.2062982C>T	-	-	TSC2_000070	-	PubMed: Ding, 2020	-	-	Germline	-	-	-	-	-	DNA	SEQ	-	-	TSC	80	PubMed: Ding, 2020	-	M	-	China	-	-	-	-	-	1	Yifeng Ding
+/.	14	c.1372C>T	r.(?)	p.(Arg458*)	-	-	Unknown	-	pathogenic (dominant)	g.2112983C>T	g.2062982C>T	p.R458*	-	TSC2_000070	-	Unpublished	-	-	De novo	-	1/3 individuals tested has the variant	-	-	-	DNA	MLPA, SEQ, SEQ-NG	Blood	-	TSC	-	Unpublished	No family history of TSC	M	?	-	-	-	-	-	-	1	Rosemary Ekong
+/.	14	c.1372C>T	r.(?)	p.(Arg458*)	-	-	Unknown	-	pathogenic (dominant)	g.2112983C>T	-	exon 13	-	TSC2_000070	-	unpublished	-	-	Germline	?	-	-	-	-	DNA	DHPLC, SEQ	Blood	Diagnostic testing	TSC	-	unpublished	No other family member tested	M	?	-	-	-	-	-	-	1	Rosemary Ekong
+/.	14	c.1372C>T	r.(?)	p.(Arg458*)	-	-	Unknown	-	pathogenic (dominant)	g.2112983C>T	-	exon 13	-	TSC2_000070	variant detected as mosaic (9%)	unpublished	-	-	De novo	?	1/3 individuals tested has the variant	-	-	-	DNA	DHPLC, SEQ, SEQ-NG	Blood	Diagnostic testing	TSC	-	unpublished	patient reported as mosaic (9%); both parents tested and variant absent	F	?	-	-	-	-	-	-	1	Rosemary Ekong
+/.	14	c.1372C>T	r.(?)	p.(Arg458*)	-	-	Unknown	ACMG	pathogenic (dominant)	g.2112983C>T	g.2062982C>T	exon 13	-	TSC2_000070	-	PubMed: Ogorek, 2020	-	-	Germline	?	-	-	-	-	DNA	SEQ-NG-I	Blood	Targeted massive parallel sequencing, mean target coverage of 327× to 1614× (median 716×)	TSC	01-050	PubMed: Ogorek, 2020	infant with drug resistant epilepsy; no history of TSC in the family; patient had first subclinical/clinical seizures at day 25 during the study	F	?	-	-	-	-	-	-	1	Rosemary Ekong
+/.	14	c.1372C>T	r.(?)	p.(Arg458*)	Hamartin binding domain	-	Unknown	-	pathogenic	g.2112983C>T	g.2062982C>T	p.R458*	-	TSC2_000070	variant in angiofibroma (7.3% MAF); seen in AF with TSC2 c.976-15G>A (8.9% MAF) and TSC2 missense c.4490C>T (1.3% MAF); freq in blood & saliva similar to normal controls; NGS read depth >500x	PubMed: Tyburczy, 2015	-	-	De novo	-	-	DdeI+, AvaI-	-	-	DNA	SEQ-NG-I	Angiofibroma, normal skin	amplicon NGS	TSC	P14	PubMed: Tyburczy, 2015; PubMed: Giannikou, 2019	23 year old TSC patient with NMI status (previous Sanger SEQ and TSC2 MLPA negative); no FH of TS; has TSC2 splice variant c.976-15G>A, TSC2 nonsense c.1372C>T and TSC2 missense c.4490C>T in facial angiofibroma; both parents tested and variants not found	M	-	-	-	-	-	-	-	1	Rosemary Ekong
+/.	14	c.1372C>T	r.(?)	p.(Arg458*)	-	-	Unknown	ACMG	pathogenic (dominant)	g.2112983C>T	g.2062982C>T	exon 13	-	TSC2_000070	variant at 6% MAF	PubMed: Ogorek, 2020	-	-	Unknown	?	-	-	-	-	DNA	SEQ-NG-I	Blood	Targeted massive parallel sequencing, mean target coverage of 327× to 1614× (median 716×)	TSC	02-001	PubMed: Ogorek, 2020	infant is a mosaic; no history of TSC in the family; patient had first subclinical/clinical seizures at day 200 during the study	M	?	-	-	-	-	-	-	1	Rosemary Ekong
+/.	-	c.1372C>T	r.(?)	p.(Arg458Ter)	-	-	Unknown	-	pathogenic	g.2112983C>T	-	-	-	TSC2_000070	-	-	-	rs45517169	Unknown	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
+/.	14	c.1372C>T	r.(?)	p.(Arg458*)	-	-	Unknown	ACMG	pathogenic (dominant)	g.2112983C>T	g.2062982C>T	-	-	TSC2_000070	mosaic variant: minor allele frequency 23.2%	PubMed: Milon 2024; PubMed: Milon 2024	-	-	De novo	-	-	-	-	-	DNA	SEQ, SEQ-NG-IT	Fetal lung	-	TSC	-	PubMed: Milon 2024; PubMed: Milon 2024	no family history of TSC; prenatally diagnosed cardiac rhabdomyoma (≥2); both parents tested negative; termination of pregnancy at 32+0	-	-	-	-	-	-	-	-	1	Sarah Prestwich

Legend

How to query

Assessment of functional consequences - Our conclusions on the functional consequences of variants are based on the type of variant, results of in vitro functional tests (doi: 10.1002/humu.21451; doi: 10.1002/humu.22202; doi: 10.1002/humu.23963), population frequencies, output from in silico splice site prediction algorithms, and any clinical/family data available to us. We also have output from protein prediction programs in this database for comparison purposes and they are not considered in our assessment of pathogenicity. PolyPhen Predictions - Note that these results are from PolyPhen-2 and only the HumDiv classification is shown.

Global Variome shared LOVD

TSC2 (tuberous sclerosis 2)